Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients

International Journal of Oncology

Volumn 29, Issue 1, 2006, Pages 65-72

  Aoe, Keisuke ^a   Hiraki, Akio ^a   Yamazaki, Koichi ^b   Nakamura, Yuichi ^b   Murakami, Tomoyuki ^a   Maeda, Tadashi ^a   Nishimura, Masaharu ^b   Sugi, Kazuro ^a   Ueoka, Hiroshi ^a  

^a NATIONAL SANYO HOSPITAL   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnostic testing; Lung cancer; Pleural fluid; RCAS1; Survival outcome

Indexed keywords

EBAG9 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOLOGY; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PLEURA EFFUSION; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 35248899240     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.1.65     Document Type: Article

References (27)

1. Reed CE: Management of the malignant pleural effusion. In: Lung Cancer. Principles and Practice. Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds). Lippincott-Raven, Philadelphia, pp643-654, 1996.
2. Aoe K, Hiraki A, Murakami T, Eda R, Maeda T, Sugi K and Takeyama H: Diagnostic significance of interferon-γ in tuberculous pleural effusions. Chest 123: 740-744, 2003.
3. Aoe K, Hiraki A, Murakami T, Murakami K, Makihata K, Takao K, Eda R, Maeda T, Sugi K, Darzynkiewicz Z and Takeyama H: Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. Int J Mol Med 12: 193-198, 2003.
4. Hiraki A, Aoe K, Matsuo K, Murakami K, Murakami T, Onoda T, Sugi K, Takeyama H and Eda R: Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion. Int J Tuberc Lung Dis 7: 1172-1177, 2003.
5. Hiraki A, Aoe K, Eda R, Maeda T, Murakami T, Sugi K and Takeyama H: Comparison of six biologic markers for the diagnoses of tuberculous pleuritis. Chest 125: 987-989, 2004.
6. Fraser RS, Muller NL, Colman NC and Pare PD: Pleural disease. In: Fraser and Pare's Diagnosis of Disease of the Chest. Fraser RS, Muller NL, Colman NC and Pare PD (eds). Vol. 4, fourth edition. W.B. Saunders Company, Philadelphia, pp2739-2779, 1999.
7. Mohanty SK and Dey P: Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 79: 569-574, 2003.
8. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H and Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77: 1501-1509, 1996.
9. Nakashima T, Sonoda K and Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 5: 938-942, 1999.
10. Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Katoh K, Taguchi K, Nakamuta M, Nawata H and Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated disease as well as in carcinomas of biliary tract. J Hepatol 36: 786-792, 2002.
11. Aoe K, Hiraki A, Maeda T, Murakami T, Yamazaki K, Sugi K and Takeyama H: Soluble receptor-binding cancer antigen expressed on SiSo cells (RCAS1) in pleural fluid: A potential diagnostic marker for malignant pleural effusion. Chest 126: 1195-1197, 2004.
12. Leelawat K, Watanabe T, Nakajima M, Tujinda S, Suthipintawong C and Leardkamolkarn V: Upregulation of tumor associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol 56: 764-768, 2003.
13. Watanabe H, Enjoji M, Nakashima M, Noguchi K, Kinukawa N, Sugimoto R, Kotoh K, Nakamuta M, Nawata H and Watanabe T: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J Hepatol 39: 559-563, 2003.
14. Enjoji M, Noguchi K, Watanabe H, Yoshida Y, Kotoh K, Nakashima M, Watanabe T, Nakamuta M and Nawata H: A novel tumor marker RCAS1 in a case of extramammary Paget's disease. Clin Exp Dermatol 28: 211-213, 2003.
15. Oizumi S, Yamazaki K, Nakashima M, Watanabe T, Hommura F, Ogura S, Nishimura M and Dosaka-Akita H: RCAS1 expression: A potential prognostic marker for adenocarcinoma of the lung. Oncology 62: 333-339, 2002.
16. Whiteside TL and Herberman RB: The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7: 704-710, 1995.
17. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T and Hara N: Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 92: 446-451, 2001.
18. Rousseau J, Tetu B, Caron D, Malenfant P, Cattauzzi P, Audette M, Doillon C, Tremblay JP and Guerette B: RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun 293: 1544-1549, 2002.
19. Nakakubo Y, Hida Y, Miyamoto M, Hashida H, Oshikiri T, Kato K, Suzuoka M, Hiraoka K, Ito T, Morikawa T, Okushiba S, Kondo S and Katoh H: The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 177: 101-105, 2002. (Pubitemid 34102405)
20. Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H and Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 26: 49-55, 2003.
21. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, Taguchi K, Katoh K, Shimada M, Sugimachi K, Tsuneyoshi M, Nawata H and Watanabe T: Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 168: 197-202, 2001.
22. Kubokawa M, Nakashima M, Yao T, Ito K, Harada N, Nawata H and Watanabe T: Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 19: 695-700, 2001.
23. Nakamura Y, Yamazaki K, Oizumi S, Nakashima M, Watanabe T, Dosaka-Akita H and Nishimura M: Expression of RCAS1 in human gastric carcinoma: A potential mechanism of immune escape. Cancer Sci 95: 260-265, 2004.
24. Oshikiri T, Hida Y, Miyamoto M, Hashida H, Katoh K, Suzuoka M, Nakakubo Y, Hiraoka K, Shinohara T, Itoh T, Kondo S and Katoh H: RCAS1 as a tumor progression marker: an independent negative prognostic factor in gallbladder cancer. Br J Cancer 85: 1922-1927, 2001.
25. Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K and Ishida-Yamamoto A: RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 26: 140-144, 2001.
26. Thunnissen FB, Peterse JL, van Pel R, Jansen JW, Ladde BE, Arends JW and Volvics A: Reliability of fine needle aspiration cytology for distinguishing between carcinoma, lymphoma, and sarcoma: the influence of clinical information. Cytopathology 4: 107-114, 1993.
27. Light RW: Pleural effusion. N Engl J Med 346: 1971-1977, 2002.